Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3

Overview

Journal J Cancer

Specialty Oncology

Date 2019 Jul 2

PMID 31258780

Citations 14

Authors

Yu Jin

Yuexiu Li

Xin Wang

Ya Yang

Affiliations

Soon will be listed here.

Abstract

MicroRNA-519d (miR-519d) has been reported to play important roles in tumor development and progression in multiple cancers, either as tumor suppressor or tumor promotor. However, the expression level, biological function and molecular mechanisms of miR-519d in oral squamous cell carcinoma (OSCC) remain unclear. Therefore, the aims of this study were to investigate the functional role of miR-519d in OSCC and the possible underlying regulatory mechanism. In this study, we found that miR-519d was significantly downregulated in OSCC tissues and cell lines compared with normal oral mucosae and normal oral epithelial cells. Importantly, downregulation of miR-519d was closely correlated with the lymph node metastasis, advanced tumor stage and poor overall survival of OSCC patients. Furthermore, miR-519d significantly inhibited the migration and invasion of OSCC cells. Using bioinformatics and biological approaches, we showed that miR-519d directly targeted matrix metalloproteinase-3 (MMP3), which might account for the underlying mechanism involved in the miR-519d mediated suppression of OSCC progression. What is more, miR-519d expression was inversely correlated with MMP3 expression in OSCC tissues, and high levels of MMP3 expression in OSCC tissues were also associated with the metastasis and poor prognosis of these patients. In addition, we further identified that miR-519d acted as a regulator of epithelial-mesenchymal transition (EMT) in OSCC cells. Overall, the present study highlighted miR-519d as a tumor suppressor in OSCC by targeting MMP3 and supported biological and clinical links between miR-519d-MMP3 and OSCC, thus indicating the potential therapeutic value of miR-519d for alleviating OSCC metastasis.

Citing Articles

Eslami M, Khazeni S, Mohammadi Khanaghah X, Asadi M, Ansari M, Garjan J Cancer Cell Int. 2023; 23(1):182.

PMID: 37635248 PMC: 10463971. DOI: 10.1186/s12935-023-03022-5.

Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.

Jayaraj R, Polpaya K, Kunale M, Kodiveri Muthukaliannan G, Shetty S, Baxi S Genes (Basel). 2022; 13(12).

PMID: 36553594 PMC: 9777665. DOI: 10.3390/genes13122325.

The Use of Salivary Levels of Matrix Metalloproteinases as an Adjuvant Method in the Early Diagnosis of Oral Squamous Cell Carcinoma: A Narrative Literature Review.

Monea M, Pop A Curr Issues Mol Biol. 2022; 44(12):6306-6322.

PMID: 36547091 PMC: 9776994. DOI: 10.3390/cimb44120430.

The role of tumor-associated macrophages in oral squamous cell carcinoma.

Xue Y, Song X, Fan S, Deng R Front Physiol. 2022; 13:959747.

PMID: 36105288 PMC: 9464857. DOI: 10.3389/fphys.2022.959747.

CircSEC24A (hsa_circ_0003528) interference suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells via miR-421/MMP3 axis.

Zhang B, Zhou J Bioengineered. 2022; 13(4):9049-9062.

PMID: 35400271 PMC: 9161912. DOI: 10.1080/21655979.2022.2057761.

References

Orsulic S, Huber O, Aberle H, Arnold S, Kemler R . E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci. 1999; 112 ( Pt 8):1237-45. DOI: 10.1242/jcs.112.8.1237. View

Sternlicht M, Lochter A, Sympson C, Huey B, Rougier J, Gray J . The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999; 98(2):137-46. PMC: 2853255. DOI: 10.1016/s0092-8674(00)81009-0. View

Sternlicht M, Bissell M, Werb Z . The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene. 2000; 19(8):1102-13. PMC: 2933206. DOI: 10.1038/sj.onc.1203347. View

Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O . Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005; 37(7):766-70. DOI: 10.1038/ng1590. View

Radisky D, Levy D, Littlepage L, Liu H, Nelson C, Fata J . Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 2005; 436(7047):123-7. PMC: 2784913. DOI: 10.1038/nature03688. View

Plasterk R . Micro RNAs in animal development. Cell. 2006; 124(5):877-81. DOI: 10.1016/j.cell.2006.02.030. View

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

Burns W, Twigg S, Forbes J, Pete J, Tikellis C, Thallas-Bonke V . Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol. 2006; 17(9):2484-94. DOI: 10.1681/ASN.2006050525. View

Zhang B, Pan X, Cobb G, Anderson T . microRNAs as oncogenes and tumor suppressors. Dev Biol. 2006; 302(1):1-12. DOI: 10.1016/j.ydbio.2006.08.028. View

10.

Przybylo J, Radisky D . Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace. Int J Biochem Cell Biol. 2007; 39(6):1082-8. DOI: 10.1016/j.biocel.2007.03.002. View

11.

Baltimore D, Boldin M, OConnell R, Rao D, Taganov K . MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008; 9(8):839-45. DOI: 10.1038/ni.f.209. View

12.

Lotterman C, Kent O, Mendell J . Functional integration of microRNAs into oncogenic and tumor suppressor pathways. Cell Cycle. 2008; 7(16):2493-9. PMC: 2654364. DOI: 10.4161/cc.7.16.6452. View

13.

Li J, Huang H, Sun L, Yang M, Pan C, Chen W . MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009; 15(12):3998-4008. DOI: 10.1158/1078-0432.CCR-08-3053. View

14.

Croce C . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10(10):704-14. PMC: 3467096. DOI: 10.1038/nrg2634. View

15.

Yu Z, Zhong L, Ji T, Zhang P, Chen W, Zhang C . MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol. 2010; 46(4):317-22. DOI: 10.1016/j.oraloncology.2010.02.002. View

16.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

17.

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

18.

Hou Y, Cao W, Li L, Li S, Liu T, Wan H . MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 2011; 307(2):182-90. DOI: 10.1016/j.canlet.2011.04.002. View

19.

Wang B, Komers R, Carew R, Winbanks C, Xu B, Herman-Edelstein M . Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol. 2011; 23(2):252-65. PMC: 3269175. DOI: 10.1681/ASN.2011010055. View

20.

Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G . In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol. 2012; 227(3):275-85. DOI: 10.1002/path.3995. View